InterMune (nasdaq)ITMN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Secret_Agent_Man who started this subject	4/24/2002 12:19:36 PM
From: Czechsinthemail	Read Replies (1) of 508

Looks like some exiting for the sidelines ahead of the earnings report. ITMN hasn't been performing very well lately. Someone seems to be selling any rallies, putting downward pressure on the stock But with the exception of questions about the company's valuation, the Mayo-related questions about the effectiveness of Actimmune and a possible crackdown on off-label marketing for IPF, the news background generally seems positive. I've been doing some selective buying on the dips and hoping that it's more a reflection of investor skittishness depressing biotech prices rather than any fundamental problem. Baird

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next